Abstract The literature for capacity planning and scheduling of biopharmaceutical facilities has relied on mostly discrete-time mixed-integer linear programming (MILP) formulations. This work presents a new genetic algorithm (GA) based optimisation approach for medium-term capacity planning of a multi-product, multi-suite biopharmaceutical facility using a continuous-time representation. The continuous-time model is implemented by utilising a dynamic chromosome structure capable of adapting to the problem by growing in length from a single gene corresponding to a production campaign in a manufacturing schedule. The proposed optimisation approach is validated on a previously published industrial case study solved with a continuous-time MILP formulation. The results indicate that the proposed approach is both robust and fast at solving a medium-term scheduling problem from biopharmaceutical industry.
[1]
Suzanne S Farid,et al.
Strategic Biopharmaceutical Portfolio Development: An Analysis of Constraint‐Induced Implications
,
2008,
Biotechnology progress.
[2]
Yuhong Zhou,et al.
Medium Term Planning of Biopharmaceutical Manufacture using Mathematical Programming
,
2005,
Biotechnology progress.
[3]
Munawar A. Shaik,et al.
Multi-period scheduling of a multi-stage multi-product bio-pharmaceutical process
,
2013,
Comput. Chem. Eng..
[4]
Suzanne S Farid,et al.
Capacity Planning for Batch and Perfusion Bioprocesses Across Multiple Biopharmaceutical Facilities
,
2014,
Biotechnology progress.